27 October 2025 | Monday | News
Image Source : Public Domain
Pfizer Singapore and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced that the Health Sciences Authority has approved the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in individuals 6 months of age and older, according to official recommendations*. This marks Singapore as the first country in Southeast Asia to receive full approval for the latest COVID-19 vaccine.
The LP.8.1 sublineage selection is based on guidance from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and World Health Organization (WHO) which stated that LP.8.1 is the preferred sublineage of a monovalent JN.1-lineage-based COVID-19 vaccine for use in the U.S. beginning in fall 2025.
"Pfizer remains steadfast in our commitment to protecting public health through science and innovation. The approval of this updated LP.8.1-adapted monovalent COVID-19 vaccine marks another important milestone in our ongoing efforts to provide communities with timely access to protection. We echo the government's call for proactive healthcare and prevention measures." said Ms. Deborah Seifert, Cluster Lead, Pfizer Malaysia, Indonesia, Singapore, Philippines. "By empowering individuals with the tools to safeguard themselves and those around them, we reinforce our belief in a life-course approach to immunization—one that prioritizes prevention, resilience, and equity for all."
"As new COVID-19 variants continue to emerge, vigilance remains our shared responsibility. Under Singapore's comprehensive national COVID-19 vaccination program, the COVID-19 vaccine remains free to the public* and is available at selected GP clinics and polyclinics**, empowering us to stay ahead of the virus and protect our communities. For high-risk groups, including seniors and those with underlying health conditions, updated vaccines offer essential protection against severe disease and hospitalization," said Dr. Aziz Noordin, Family Physician, Tampines Family Medicine Clinic. "It is worth consulting your healthcare provider about protection against COVID-19."
|
*Vaccination is free of charge under the National Vaccination Programme (NVP) for all Singapore Citizens, Permanent Residents, Long Term Pass Holders and certain Short-Term Pass holders.[2] |
|
**All individuals eligible for COVID-19 vaccination may book an appointment at selected General Practitioner (GP) clinics participating in NVP through the link here, or selected polyclinics via the HealthHub booking system. |
###
Most Read
Bio Jobs
News
Editor Picks